World No. 1 Tennis Star Aryna Sabalenka Joins Prenetics’ IM8 Health as Global Ambassador and Shareholder

Rhea-AI Summary

Prenetics Global Limited (NASDAQ: PRE) announced that world No. 1 tennis star Aryna Sabalenka has joined IM8 Health as both global ambassador and shareholder, marking the first time a current athlete has become a shareholder in Prenetics.

IM8, a premium supplements brand co-founded by David Beckham, has achieved remarkable growth since its December 2024 launch, generating over $50 million in Annual Recurring Revenue and serving 60,000+ customers with more than 5 million supplement servings. The company's NSF Certified for Sport® Daily Ultimate Essentials product has been part of Sabalenka's daily routine since early 2025, contributing to her successful season including titles in Brisbane, Miami, and Madrid.

Positive

• Rapid revenue growth achieving $50M+ Annual Recurring Revenue in just 6 months
• Strong customer base of 60,000+ users with over 5 million servings delivered
• Partnership with world No. 1 tennis star adds credibility and market visibility
• NSF Certified for Sport® certification ensures product quality and safety
• Revenue velocity exceeds typical supplement launch benchmarks by 500%

Negative

• None.

Insights

Marketing and Brand Development Strategist

Prenetics' IM8 reveals impressive $50M+ ARR and secures world No. 1 tennis star Sabalenka as both ambassador and shareholder.

This partnership between Prenetics' IM8 and Aryna Sabalenka represents a significant strategic win beyond typical celebrity endorsement. Having the world's top-ranked tennis player not just endorse but invest financially in the company creates powerful authenticity rarely seen in supplement marketing. This shareholder-ambassador hybrid model elevates credibility substantially.

The financial metrics disclosed are remarkable for a supplement startup. Achieving $50M+ in annual recurring revenue within just six months places IM8 in rarefied territory for growth velocity—500% above industry benchmarks according to the release. The 60,000+ customer base and 5 million servings demonstrate impressive market penetration and customer retention.

Timing this announcement days before Wimbledon maximizes media exposure during tennis's highest-visibility period. The NSF Certified for Sport® designation addresses a critical barrier in athlete endorsements amid growing concerns about supplement contamination in professional tennis.

What's particularly valuable is the direct connection to both David Beckham (co-founder) and now Sabalenka, creating a powerful dual-sport celebrity association that appeals to diverse demographic segments. This crossover appeal between soccer and tennis fans broadens IM8's potential market considerably while reinforcing its premium positioning.

The strategic involvement of scientific advisors from prestigious institutions like Mayo Clinic further distinguishes IM8 from competitors in the crowded supplement space, potentially justifying premium pricing and supporting long-term customer value.

Financial Analyst

The metrics revealed in this announcement paint an extraordinary growth picture for Prenetics' IM8 brand. Generating $50M+ in annual recurring revenue within just six months of launch represents exceptional performance in the supplement industry. The 500% outperformance versus typical successful supplement launches mentioned by analysts signals that IM8 has broken through typical growth constraints.

The 60,000+ customer base provides a valuable recurring revenue foundation, with metrics suggesting an average annual customer value of approximately $833 per user. This high customer value indicates premium positioning and successful monetization. The 5 million servings data point implies strong consumption patterns and potential reorder rates.

Securing Sabalenka as both ambassador and shareholder creates alignment between brand promotion and financial interests—a structure that often yields stronger long-term value than standard endorsement deals. While financial terms weren't disclosed, this arrangement likely provides IM8 with marketing efficiencies compared to traditional athlete endorsements that require large upfront guarantees.

The NSF Certified for Sport® designation represents a strategic advantage in penetrating the highly profitable sports nutrition segment. This certification requires rigorous testing and quality controls, creating barriers to entry that protect margins and justify premium pricing.

This rapid revenue scaling showcases Prenetics' ability to successfully diversify beyond its original genomics testing focus, potentially providing investors with improved growth visibility. The direct-to-consumer subscription model (implied by the ARR metric) typically delivers higher margins and better forward revenue predictability than wholesale-dependent supplement businesses.

• Aryna Sabalenka becomes first-ever current athlete shareholder in Prenetics, listed on the NASDAQ: (PRE)
  
  
• In just six months, IM8 is one of the fastest growing supplement brands in the world, generating an extraordinary US$50m+ Annual Recurring Revenue
  
  
• IM8 has built a loyal customer base of 60,000+ users who have consumed over 5 million servings
  
  
• IM8, co-founded by David Beckham is available at www.im8health.com
  

CHARLOTTE, N.C., June 26, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE), a leading consumer health sciences company, announced today at a special event at Wimbledon House that IM8, its premium supplements brand co-founded by David Beckham, has partnered with world No. 1 tennis star Aryna Sabalenka as its newest global ambassador and shareholder. The announcement comes just days before the start of Wimbledon on June 30th, where Sabalenka will be competing as one of the tournament favorites.

The partnership marks a significant milestone for both Sabalenka and IM8, as this represents the first time the tennis champion has endorsed a supplement brand. The collaboration was born organically after Sabalenka experienced remarkable benefits from using IM8's Daily Ultimate Essentials, which is NSF Certified for Sport®, since the beginning of 2025.

Sabalenka, who is preparing for Wimbledon after an impressive first half of 2025 that saw her claim three prestigious titles in Brisbane, Miami, and Madrid, has reported significant improvements in energy, endurance, digestion, and cognitive focus since incorporating IM8 into her daily routine. Her entire team, including her tennis coaches and personal trainer, have also become regular users of the product.

"As a professional athlete, I'm extremely cautious about what I put in my body. I've tried countless supplements and naturally am always skeptical. Trust is everything," said Sabalenka. "After my coach recommended IM8, I noticed a difference within weeks – better energy throughout long matches, faster recovery, and improved focus when it matters most. What truly won me over was their deep scientific advisory board with experts from Mayo Clinic and other leading institutions, combined with the fact that IM8 is NSF Certified for Sport®. This gives me absolute confidence in its purity, quality, and scientific foundation. This partnership goes far beyond a typical endorsement – I've become a shareholder in Prenetics because I genuinely believe in what this product delivers. Being part of a brand co-founded by David Beckham, who understands the demands of elite sports at the highest level, makes this even more special. The results I've experienced firsthand have transformed my approach to optimal nutrition.”

Sabalenka added, "While being constantly on the road, it’s incredibly valuable knowing that IM8 can replace 16 supplements with clinical dosages– it's simplified my nutrition regimen while ensuring I get everything I need. It's become an essential part of my daily routine and my entire team's regimen as well. I'm truly excited about the entire IM8 team and what they're building – their commitment to quality and innovation in supplements is something I wanted to be part of beyond just being an ambassador."

"I'm absolutely thrilled to welcome Aryna to the IM8 family – not just as our global ambassador, but as a shareholder who truly believes in what we're building," said Danny Yeung, CEO of Prenetics, the parent company of IM8. "What makes this partnership extraordinary is that Aryna's journey with IM8 began organically through her performance coach, experiencing the benefits firsthand as a genuine customer before we ever discussed an official relationship. Aryna represents the pinnacle of athletic excellence, mental strength, and professionalism – qualities that perfectly align with our brand values. When an athlete of her caliber not only uses the product but also invests in the company, it speaks volumes about the quality and efficacy of what we've created. Her authentic experience and passionate advocacy for IM8 reinforces our mission to provide premium, science-backed supplements that deliver real results for everyone from elite athletes to everyday health enthusiasts."

The partnership comes at a time when supplement safety and quality are increasingly important topics in professional tennis. Recent high-profile cases have highlighted the risks athletes face with contaminated supplements, making IM8's NSF Certified for Sport® designation particularly significant. This certification ensures that products are regularly tested for more than 280 substances prohibited in sport and confirms that they contain the ingredients listed on the label without unsafe levels of contaminants.

Since its launch in December 2024, IM8 has experienced extraordinary growth, achieving US$50m+ Annual Recurring Revenue and serving more than 60,000 customers and delivering over 5 million servings of its premium supplements. This remarkable trajectory places IM8 among the fastest growing supplement brands globally. Industry analysts have noted that IM8's revenue velocity in its first six months exceeds typical benchmarks for successful supplement launches by 500%.

The special announcement event at Wimbledon House featured Sabalenka alongside Prenetics executives, IM8's Scientific Advisory Board members, including Dr. Dawn Mussallem from Mayo Clinic and Dr. Ara Suppiah, Functional Sports Physician, as well as media, and friends of the brand. The gathering highlighted the significance of this partnership as Sabalenka prepares for one of tennis's most prestigious tournaments.

IM8's Daily Ultimate Essentials are available at www.im8health.com.

Press Kit: HERE

About Prenetics
Prenetics (NASDAQ:PRE), a leading health sciences company, is dedicated to advancing consumer health. Our consumer initiative is led by IM8, a fast-growing health and wellness brand, Europa, one of the largest sports distribution companies in the USA, and CircleDNA, a leading direct-to-consumer DNA test. As the first healthcare company to establish a Bitcoin treasury with its initial $20 million Bitcoin purchase and board-approved comprehensive Bitcoin strategy, Prenetics is pioneering the intersection of healthcare innovation and digital asset adoption. Each of Prenetics' units synergistically enhances our global impact on health, embodying our commitment to "enhancing life through science". To learn more please visit prenetics.com and IM8health.com

About IM8
IM8 is the pinnacle of premium core nutrition, born from a collaboration between David Beckham as a co-founding partner, and an elite team of scientists spanning medical professionals, academia and space science. Combining cutting-edge science with nature’s most potent ingredients, IM8 delivers a holistic, science-backed approach to health, empowering you to live your most vibrant life. IM8’s flagship product, Daily Ultimate Essentials is an all-in-one powder supplement engineered to replace 16 different supplements in a delicious drink and is NSF Certified for Sport, non-GMO, vegan, free from common allergens, and contains no artificial flavors, colors or sweeteners. IM8 is a 100% owned subsidiary of Prenetics (NASDAQ: PRE), a leading global health sciences company dedicated to advancing consumer health.

About Aryna Sabalenka
Aryna Sabalenka is the current world No. 1 tennis player and one of the sport's most dominant forces. In 2025 alone, she has claimed three prestigious titles in Brisbane, Miami, and Madrid, continuing her impressive career trajectory. Known for her powerful playing style and mental fortitude, Sabalenka has established herself as one of tennis's premier athletes.

Media Contact:

Angela Cheung
Investor Relations / Corporate Finance
Prenetics Global Limited
angela.hm.cheung@prenetics.com

Danielle Mulholland
Jack Taylor Public Relations
IM8@jacktaylorpr.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/7953550c-a837-48d1-be27-1a4ea59ba94c

FAQ

What is Aryna Sabalenka's role with Prenetics (NASDAQ: PRE)?

Sabalenka has joined IM8 Health as both a global ambassador and shareholder, becoming the first current athlete shareholder in Prenetics.

How much revenue has IM8 Health generated since its launch?

Since its December 2024 launch, IM8 has generated over $50 million in Annual Recurring Revenue and served more than 60,000 customers.

What certifications does IM8's supplement have for professional athletes?

IM8's Daily Ultimate Essentials is NSF Certified for Sport®, ensuring testing for over 280 prohibited substances and confirming ingredient accuracy.

Who are the key partners involved in IM8 Health?

IM8 Health is co-founded by David Beckham and includes scientific advisors from Mayo Clinic. World No. 1 tennis star Aryna Sabalenka has joined as global ambassador and shareholder.

How many customers does IM8 Health currently serve?

IM8 Health has built a customer base of over 60,000 users who have consumed more than 5 million servings of their supplements.